Information  X 
Enter a valid email address

Company Name matching 'DBV Technologies S.A.'

Date
Time Source
Company
Announcement
05 May 2021 10:00 pm GNW   DBV Technologies S.A. DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021
03 May 2021 6:30 am GNW   DBV Technologies S.A. DBV Technologies Reports Q1 2021 Financial Results
29 Apr 2021 6:30 am GNW   DBV Technologies S.A. DBV Technologies to Participate in Upcoming Investor Conferences
28 Apr 2021 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
  6:30 am GNW   DBV Technologies S.A. Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic
02 Apr 2021 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors
01 Apr 2021 11:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021
26 Mar 2021 8:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual General Meeting
17 Mar 2021 10:30 pm GNW   DBV Technologies S.A. DBV Technologies Announces Filing of 2020 Annual Report on Form 10-K and 2020 Universal Registration Document
12 Mar 2021 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2021
11 Mar 2021 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
05 Mar 2021 9:30 pm GNW   DBV Technologies S.A. DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
03 Mar 2021 11:00 pm GNW   DBV Technologies S.A. DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results
01 Mar 2021 6:30 am GNW   DBV Technologies S.A. DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021
22 Feb 2021 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer
19 Feb 2021 6:30 am GNW   DBV Technologies S.A. DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference
11 Feb 2021 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021
29 Jan 2021 9:30 pm GNW   DBV Technologies S.A. Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
14 Jan 2021 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years
07 Jan 2021 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process
05 Jan 2021 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020
15 Dec 2020 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020
24 Nov 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Leadership Changes
11 Nov 2020 9:30 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020
10 Nov 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies to Highlight Data on Viaskin™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020
09 Nov 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies to Participate in Upcoming Investor Conferences
02 Nov 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency 
30 Oct 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Reports September 30, 2020 Cash Position
08 Oct 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2020
15 Sep 2020 9:30 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and  total number of shares of the Company as of August 31, 2020
09 Sep 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Leadership Changes
02 Sep 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies to Participate in Multiple September Investor Conferences
12 Aug 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020
04 Aug 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years
31 Jul 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Reports First Half 2020 Financial Results
20 Jul 2020 9:01 pm GNW   DBV Technologies S.A. Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
15 Jul 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020
10 Jul 2020 2:00 pm GNW   DBV Technologies S.A. DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology
26 Jun 2020 7:30 am GNW   DBV Technologies S.A. DBV Technologies Provides Operational and Business Update
11 Jun 2020 9:01 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2020
04 Jun 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies to Present Data on Epicutaneous Immunotherapy and Food Allergy Quality of Life at EAACI Digital Congress 2020
02 Jun 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference
12 May 2020 9:01 pm GNW   DBV Technologies S.A. Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020
30 Apr 2020 9:01 pm GNW   DBV Technologies S.A. DBV Technologies Reports March 31, 2020 Cash Position
20 Apr 2020 9:01 pm GNW   DBV Technologies S.A. DBV Technologies Announces Results of its 2020 Ordinary and Extraordinary General Meeting
15 Apr 2020 11:00 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
10 Apr 2020 9:01 pm GNW   DBV Technologies S.A. Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic
30 Mar 2020 9:01 pm GNW   DBV Technologies S.A. Ordinary and Extraordinary General Meeting of April 20, 2020
26 Mar 2020 3:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company
20 Mar 2020 8:15 pm GNW   DBV Technologies S.A. DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F
17 Mar 2020 8:00 pm GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020
16 Mar 2020 8:30 pm GNW   DBV Technologies S.A. DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years
04 Mar 2020 9:30 pm GNW   DBV Technologies S.A. DBV Technologies Reports Full-Year 2019 Financial Results and Provides Business Update
  9:01 pm GNW   DBV Technologies S.A. DBV Technologies Announces Closing of Underwriters’ Option to Purchase Additional Ordinary Shares in the Form of American Depositary Shares in Connection With its Global Offering
02 Mar 2020 6:30 am GNW   DBV Technologies S.A. DBV Technologies Announces Partial Exercise of Underwriters’ Option to Purchase Additional Shares in Connection With its Global Offering of Ordinary Shares in the Form of American Depositary Shares (ADSs)
24 Feb 2020 9:00 pm GNW   DBV Technologies S.A. DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020
21 Feb 2020 2:29 pm GNW   DBV Technologies S.A. DBV Technologies Announces FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment of Peanut Allergy in Children
10 Feb 2020 9:00 pm GNW   DBV Technologies S.A. DBV Technologies to Present at the SVB Leerink 9th Annual Global Healthcare Conference
07 Feb 2020 1:00 am GNW   DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2020 and February 4, 2020
06 Feb 2020 9:01 pm GNW   DBV Technologies S.A. DBV Technologies Announces Appointment of Pascal Wotling as Chief Technical Operations Officer


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t